Grow AI. Fast.
AI can revolutionise the way we do everything. Yet adoption is slow because humans need to manually curate vast quantities of data to maintain a single AI.
No more. With our technology you can build & grow AI-powered applications faster than ever before. Simply log in to our web platform and create your own AI solution (early access now available for image data!).
Grow AI with 100x less data and effort
We created a new generation of AI algorithms that require 100 times less data curation to work, enabling you to rapidly build and grow powerful AI solutions for new applications.
On our early-access platform users can submit and annotate image data (e.g. microscopy or satelite images). A few images are enough to teach our engine to reproduce your annotations that can be combined with a wide range of customisable quantification algorithms to generate the insight that your business requires. Over time you can keep improving your AI by adding more data and annotation.
See our case studies for applications that helped clients create AIs that are less prone to human biases, offer valuable insights, and speed up data analysis workflows.
Deploy custom AI within hours
Keep up with changing world by adding more data
AI solutions come with powerful & customisable analytics so that you can extract the insights you need
Quantifying human organoid shapes and sizes using AI segmentation on 3D image data
What clients say about us
“The team at deepMirror has been incredibly responsive and has created a custom output program specifically tailored for the needs of our lab”
“Compared to most existing tracking software, KymoBulter identifies a significantly lower number of false positive/negative tracks and highly suitable for analysing kymographs originated from biological samples. Customer service is very efficient and helpful in answering questions related to the usage and performance of KymoButler, which made it easy to obtain satisfactory results.”
We did it! It feels like yesterday when we founded DeepMirror in 2019 as researchers at the University of Cambridge, and now we raised our first round of financing to productise our proprietary technology that enables the effortless adoption of AI for biomedical discoveries.